{"id":"F2009L03483","name":"Therapeutic Goods (Listing) Notice 2009 (No. 2)","slug":"therapeutic-goods-listing-notice-2009-no-2","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":141178,"registerId":"commonwealth-F2009L03483-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2009 (No. 2)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2009 (No. 2)\n\nI, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the ARTG) for listed goods:\n\na) preparations for the purposes Item 3 of Part 1 of Schedule 4 of the Regulations for oral use that contain, as their therapeutically active ingredient, sodium citrate.\n\nAND\n\nb) preparations for the purposes Item 3 of Part 1 of Schedule 4 of the Regulations for oral use that contain, as their therapeutically active ingredient, sodium acid citrate.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the ARTG for listed goods.\n\nDated this 1st day of September 2009\n\n\\[signed by\\]\n\nRohan Hammett\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":3055},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice maintains its original narrow scope—temporarily listing specific citrate salt preparations pending permanent regulatory amendment. No expansion beyond the two specified active ingredients."},"complexity_factors":["Very short instrument with only two operative paragraphs","Relies on external references to the Therapeutic Goods Regulations (Schedule 4, Part 1, Item 3) without reproducing that text","Contains an automatic sunset clause tied to future regulatory amendments","Limited scope to two specific chemical compounds and one administration route (oral)"],"plain_english_summary":"This notice allows specific over-the-counter medicines to be legally supplied in Australia. It temporarily adds oral preparations containing **sodium citrate** or **sodium acid citrate** to the Australian Register of Therapeutic Goods (ARTG) as \"listed goods.\"\n\n**What this means:**\n- **Who is affected:** Companies manufacturing or importing oral medicines that contain these citrate salts as the main active ingredient.\n- **What changes:** These products can now be listed on the ARTG—a category for lower-risk medicines—without requiring the stricter \"registered\" approval process.\n- **Why it matters:** This provides a legal supply pathway for these citrate preparations while permanent regulations are being developed to cover them.\n- **How long it lasts:** The notice commences the day after registration and automatically ceases once the Therapeutic Goods Regulations are amended to permanently include these ingredients."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2009-no-2","history":"/api/acts/therapeutic-goods-listing-notice-2009-no-2/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2009-no-2/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2009-no-2/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2009-no-2/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2009-no-2/documents"}}